Table 4.
Case series since 2000 of resected fourth ventricle ependymomas (values displayed are restricted to fourth ventricle ependymomas)
| Study | Total patients (adults) | Ependymomas (4th ventr.) | Complete removal (GTR/ependymoma) | Cranial nerve deficits | Mortality |
|---|---|---|---|---|---|
| Chai et al. [40] | 27 | 13 | 46.2% (6/13) | – | 0/27 |
| Rajesh et al. [41] | 15 | 1 | 0% (0/1) | – | 0/1 |
| Zaheer et al. [28] | 20 | 2 | 50.0% (1/2) | 0% | 0/2 |
| El-Bahy et al. [27] | 16 | 4 | 25.0% (1/4) | 50.0% | 0/4 |
| Tomasello et al. [42] | 45 | 11 | 91.0% (10/11) | 6.7% | – |
| Winkler et al. [14] | 22 | 22 | 82.0% (18/22) | 26.0% | 0/22 |
| Gök et al. [43] | 21 | 5 | 80.0% (4/5) | 20.0% | 0/5 |
| Spagnoli et al. [44] | 26 | 26 | 69.0% (18/26) | – | 1/26 |
| Aftahy et al. (present series) | 45 | 12 | 83.3% (10/12) | 8.3% | 0/7 |